Solriamfetol’s Benefits for Daytime Sleepiness and Cognition Presented at NEI Congress

Summary: Axsome Therapeutics Inc presented data at NEI Congress 2024 on solriamfetol’s impact on excessive daytime sleepiness and cognitive function in patients with obstructive sleep apnea and narcolepsy. These findings, part of Axsome’s broader research portfolio, included insights from both real-world studies and clinical trials. Notable presentations focused on solriamfetol’s impact on wakefulness and cognitive…

Read More

New HealthGPS Service Empowers Users to Track Sleep, Stress, and Metabolism

Summary: Salimetrics has launched HealthGPS, a consumer-focused service that leverages minimally invasive saliva testing for at-home assessments aimed at optimizing sleep, managing stress, and improving metabolism. By allowing users to track changes in their health over time, HealthGPS provides personalized insights, helping individuals make informed lifestyle choices to enhance their wellness. One of its core…

Read More